Stockreport

Unicycive Therapeutics Announces Full Year 2023 Financial Results and Provides Business Update [Yahoo! Finance]

Unicycive Therapeutics, Inc.  (UNCY) 
PDF – UNI-494 Phase 1 Single Ascending Dose Portion of Clinical Trial Complete – LOS ALTOS, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasda [Read more]